Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Publication Information:
      Centers for Disease Control MMWR Office, 2024.
    • Publication Date:
      2024
    • Abstract:
      Respiratory syncytial virus (RSV) is the most common cause of hospitalization among U.S. infants. CDC recommends RSV vaccination for pregnant persons or administration of RSV antibody (nirsevimab) to infants aged
    • ISSN:
      1545-861X
      0149-2195
    • Accession Number:
      10.15585/mmwr.mm7338a2
    • Rights:
      URL: http://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
    • Accession Number:
      edsair.doi.dedup.....8b943ed73de7e02159bc86eee47acb2b